Daily SignalsNeutral
2494 companies scored · 2026-10-14 run in progress: 870 of ~5379 signals so far · Total · absolute moveSwitch to Alpha · 30D 90D
Distribution of the day's forecasts
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
69 companies
Sorted by 90D forecast ↓
| Ticker | Rating | 90D | Δ |
|---|---|---|---|
| XTLBXTL BIOPHARMACEUTICALS LTD | +2.61% | · | |
| TLRYTilray Brands, Inc. | +2.58% | · | |
| IONSIONIS PHARMACEUTICALS INC | +2.57% | · | |
| OCULOCULAR THERAPEUTIX, INC | +2.53% | · | |
| SABSSAB Biotherapeutics, Inc. | +2.51% | · | |
| VTRSViatris Inc | +2.50% | · | |
| PAHCPHIBRO ANIMAL HEALTH CORP | +2.47% | · | |
| AMRNAMARIN CORP PLC\UK | +2.46% | · | |
| NWBONORTHWEST BIOTHERAPEUTICS INC | +2.44% | · | |
| MSLESatellos Bioscience Inc. | +2.41% | · | |
| AMPHAmphastar Pharmaceuticals, Inc. | +2.35% | · | |
| LABSTANDARD BIOTOOLS INC. | +2.29% | · | |
| MOLNMOLECULAR PARTNERS AG | +2.29% | · | |
| AGIOAGIOS PHARMACEUTICALS, INC. | +2.27% | · | |
| ZLABZai Lab Ltd | +2.19% | ▲ 1 | |
| CRMDCorMedix Inc. | +2.16% | ▲ 1 | |
| QUREuniQure N.V. | +2.16% | · | |
| BLRXBioLineRx Ltd. | +2.15% | · | |
| LFCRLIFECORE BIOMEDICAL, INC. \DE\ | +2.15% | · |
By sector
Median 90D forecast per sector. Click to filter.
Rating changes
Unlock the full ranking
Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.
See plans Create a free accountRatings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.